The Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium is a public-private partnership with the mission accelerating the development of more effective therapies for patients. Our goal is to transform drug discovery from a slow, sequential, and high-failure process into a rapid, integrated, and patient-centric model. We are integrating high performance computing, diverse biological data, and emerging biotechnologies to create a new pre-competitive platform for drug discovery.
Company Details
- Employees
- 12
- Founded
- -
- Address
- San Francisco, Ca 94158, Us
- in****@****nce.org
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- atomscience.org
- Keywords
- Livermore.
- HQ
- San Francisco, CA
Atom Accelerating Therapeutics For Opportunities In Medicine Questions
Atom Accelerating Therapeutics For Opportunities In Medicine's website is atomscience.org
Atom Accelerating Therapeutics For Opportunities In Medicine's LinkedIn profile is https://www.linkedin.com/company/atomscience
Atom Accelerating Therapeutics For Opportunities In Medicine has
12 employees.
View email and phone details for 12
employees at Atom Accelerating Therapeutics For Opportunities In Medicine.
Atom Accelerating Therapeutics For Opportunities In Medicine's industry is
Biotechnology Research
Atom Accelerating Therapeutics For Opportunities In Medicine's top competitors are
23andme,
Atom 6,
Objectivodata,
Master Of Molecular Science And Software Engineering (Msse), Uc Berkeley,
Nurix Therapeutics,
Hellobiome,
Atom International Limited,
Af - Level Up In Tech,
Frederick National Laboratory For Cancer Research,
Lawrence Livermore National Laboratory.
Atom Accelerating Therapeutics For Opportunities In Medicine's support email address is info@atomscience.org
Atom Accelerating Therapeutics For Opportunities In Medicine's categories are Biotechnology Research
Atom Accelerating Therapeutics For Opportunities In Medicine's founding year is 2017
